BPTH - Bio Path Holdings Stock Trading

Bio-Path Holdings Inc.(NASDAQ: BPTH) stock trading, description, contact, officers and directors.

About Bio-Path Holdings Inc.

Bio Path is engaged in the business of financing and commercializing novel cancer therapeutics acquired from MD Anderson Cancer Center. Currently in Phase human trial.

Stock Information

Bio-Path Holdings Inc. Company Name:

BPTH Stock Symbol:

NASDAQ Market:

Bio-Path Holdings Inc. Website:

BPTH - Bio Path Holdings Stock Trading

BPTH BPTH Quote BPTH Short BPTH News BPTH Articles BPTH Message Board

Get BPTH Alerts

News, Short Squeeze, Breakout and More Instantly...

BPTH - Bio-Path Granted Key Mechanism of Action U.S. Patent for BP1003

HOUSTON, June 22, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that...
BPTH - Bio-Path Holdings Reports First Quarter 2021 Financial Results

HOUSTON, May 14, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial r...
BPTH - Bio-Path Holdings to Announce First Quarter 2021 Financial Results on May 14, 2021

HOUSTON, May 07, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a ...